Long-term outcomes of frontline imatinib therapy for chronic myeloid leukemia in China

por Cheng, Fang, Yuan, Guolin, Li, Qiang, Cui, Zheng, Li, Weiming
Publicado 2023

Involvement of the arachidonic acid cytochrome P450 epoxygenase pathway in the proliferation and invasion of human multiple myeloma cells

por Shao, Jing, Wang, Hongxiang, Yuan, Guolin, Chen, Zhichao, Li, Qiubai
Publicado 2016

Non-targeted metabonomic analysis of plasma in patients with atherosclerosis by liquid chromatography-mass spectrometry

por Xia, Xianru, Li, Xiandong, Xie, Fei, Yuan, Guolin, Cheng, Dongliang, Peng, Chunyan
Publicado 2022

Impact of collection, isolation and storage methodology of circulating microvesicles on flow cytometric analysis

por KONG, FANCONG, ZHANG, LIMING, WANG, HONGXIANG, YUAN, GUOLIN, GUO, ANYUAN, LI, QIUBAI, CHEN, ZHICHAO
Publicado 2015

A Retrospective Analysis: A Novel Index Predicts Survival and Risk-Stratification for Bone Destruction in 419 Newly Diagnosed Multiple Myelomas

por Jin, Yanxia, Shang, Yufeng, Liu, Hailing, Ding, Lu, Tong, Xiqin, Tu, Honglei, Yuan, Guolin, Zhou, Fuling
Publicado 2019

Estrogen Mediates an Atherosclerotic-Protective Action via Estrogen Receptor Alpha/SREBP-1 Signaling

por Xie, Fei, Li, Xiandong, Xu, Yue, Cheng, Dongliang, Xia, Xianru, Lv, Xi, Yuan, Guolin, Peng, Chunyan
Publicado 2022

ACSL1 promotes imatinib-induced chronic myeloid leukemia cell senescence by regulating SIRT1/p53/p21 pathway

por Liu, Wen, Zhu, Xiaoying, Tang, Ling, Shen, Na, Cheng, Fanjun, Zou, Ping, You, Yong, Yuan, Guolin, Li, Qing, Zhu, Xiaojian
Publicado 2022

Tumor necrosis factor α knockout impaired tumorigenesis in chronic myeloid leukemia cells partly by metabolism modification and miRNA regulation

por Shen, Na, Liu, Songya, Cui, Jieke, Li, Qing, You, Yong, Zhong, Zhaodong, Cheng, Fanjun, Guo, An-Yuan, Zou, Ping, Yuan, Guolin, Zhu, Xiaojian
Publicado 2019

Therapeutic Plateletpheresis in Patients With Thrombocytosis: Gender, Hemoglobin Before Apheresis Significantly Affect Collection Efficiency

por Jiang, Hongqiang, Jin, Yanxia, Shang, Yufeng, Yuan, Guolin, Liu, Dandan, Li, Jianfang, Wang, Cong, Ding, Lu, Tong, Xiqin, Guo, Shishang, Gong, Fayun, Zhou, Fuling
Publicado 2021

P666: 1 YEAR RESULTS OF DASATINIB 70MG/DAY VERSUS 100MG/DAY IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE(CML-CP):A PROSPECTIVE RANDOMIZED CONTROLLED S...

por Yu, Dan, Cheng, Hui, Guo, Jingming, Jiang, Rui, Zhang, Youshan, Wan, Chucheng, Qin, Jun, Yuan, Guolin, Chen, Shiming, Yang, Zhuangzhi, Hu, Junbin, Zhang, Yicheng, LI, Weiming
Publicado 2023

COVID-19 in persons with haematological cancers

por He, Wenjuan, Chen, Lei, Chen, Li, Yuan, Guolin, Fang, Yun, Chen, Wenlan, Wu, Di, Liang, Bo, Lu, Xiaoting, Ma, Yanling, Li, Lei, Wang, Hongxiang, Chen, Zhichao, Li, Qiubai, Gale, Robert Peter
Publicado 2020

Tumor-derived extracellular vesicles inhibit osteogenesis and exacerbate myeloma bone disease

por Zhang, Liming, Lei, Qian, Wang, Hongxiang, Xu, Cuiwei, Liu, Teng, Kong, Fancong, Yang, Cui, Yan, Guoxin, Sun, Li, Zhao, Aiqi, Chen, Wenlan, Hu, Yu, Xie, Hui, Cao, Yulin, Fu, Fenfen, Yuan, Guolin, Chen, Zhichao, Guo, An-Yuan, Li, Qiubai
Publicado 2019

COVID-19 in persons with chronic myeloid leukaemia

por Li, Weiming, Wang, Danyu, Guo, Jingming, Yuan, Guolin, Yang, Zhuangzhi, Gale, Robert Peter, You, Yong, Chen, Zhichao, Chen, Shiming, Wan, Chucheng, Zhu, Xiaojian, Chang, Wei, Sheng, Lingshuang, Cheng, Hui, Zhang, Youshan, Li, Qing, Qin, Jun, Meng, Li, Jiang, Qian
Publicado 2020

Risk factors for death in 1859 subjects with COVID-19

por Chen, Lei, Yu, Jianming, He, Wenjuan, Chen, Li, Yuan, Guolin, Dong, Fang, Chen, Wenlan, Cao, Yulin, Yang, Jingyan, Cai, Liling, Wu, Di, Ran, Qijie, Li, Lei, Liu, Qiaomei, Ren, Wenxiang, Gao, Fei, Wang, Hongxiang, Chen, Zhichao, Gale, Robert Peter, Li, Qiubai, Hu, Yu
Publicado 2020

Quality‐of‐life, mental health, and perspective on TKI dose reduction as a prelude to discontinuation in chronic phase chronic myeloid leukemia

por Chen, Yilin, Xu, Na, Yang, Yunfan, Liu, Zhenfang, Xue, Mengxing, Meng, Li, He, Qun, Chen, Chunyan, Zeng, Qingshu, Zhu, Huanling, Du, Xin, Zou, Jing, He, Wenjun, Guo, Jingming, Chen, Suning, Yuan, Guolin, Wu, Hui, Hong, Mei, Cheng, Fanjun, Liu, Bingcheng, Zhang, Yanli, Li, Weiming
Publicado 2023